Moreover, the interconnected actions of estrogen, insulin, IGF-1, and hyperglycemia on the EMT of endometrial cancer may explain the increased mortality rates seen in endometrial cancer patients with obesity and diabetes (53, 61), as advanced stage is associated with significant decreases in survival in endometrial cancer (1). The gene discussed is INS; the disease is Hyperglycemia.